EMD-1214063 | CAS#1100598-32-0

Back to products

Browse products

Approved anticancer agents

Anticancer agents in trials

Anticancer agents in preclinical trials

Anticancer molecular libraries

Other drug agents

Drug intermediates

Bio-reagents and biochemicals

MedKoo product information:

EMD-1214063

EMD 1214063 is an inhibitor of MET tyrosine kinase with potential antineoplastic activity. MET tyrosine kinase inhibitor EMD 1214063 selectively binds to MET tyrosine kinase and disrupts MET signal transduction pathways, which may induce apoptosis in tumor cells overexpressing this kinase. The receptor tyrosine kinase MET (also known as hepatocyte growth factor receptor or HGFR), is the product of the proto-oncogene c-Met and is overexpressed or mutated in many tumor cell types; this protein plays key roles in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus).

Current developer: EMD Serono, Inc

MedKoo Code#: 201145
Name: EMD-1214063
CAS#: 1100598-32-0 Synonym: EMD-1214063, EMD1214063, EMD 1214063. 　 IUPAC/Chemical name: 3-(1-(3-(5-((1-methylpiperidin-4-yl)methoxy)pyrimidin-2-yl)benzyl)-1,6-dihydro-6-oxopyridazin-3-yl)benzonitrile
Chemical structure	Theoretical analysis
	MedKoo Code#: 201145 Name: EMD-1214063 CAS#: 1100598-32-0 Chemical Formula: C29H28N6O2 Exact Mass: 492.22737 Molecular Weight: 492.57 Elemental Analysis: C, 70.71; H, 5.73; N, 17.06; O, 6.50
Availability and price: EMD-1214063 (99%) is in stock. 10 mg / $350.00 50 mg / $950.00 100 mg / $1,550.00 To inquire quotation and lead time or to ask questions, please send email to sales@medkoo.com to describe your needs. A representative will respond your email shortly. We offer big discount for orders of bulk quantities.

Information about this agent

References

Contact MedKoo:

Email: sales@medkoo.com

(Keyword; CAS#; MedKoo code#)